在殖民地刺激因子-1受体 (CSF1R) 抑制剂的近期进展
Ling Peng1, Zhou Fang2, Wen Zhang2
1College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, PR China; Zhejiang Key Laboratory of Green Manufacturing Technology for Chemical Drugs, Deqing 313200, PR China.
Biochemical pharmacology
|July 28, 2025
概括
阻断殖民地刺激因子-1受体 (CSF1R) 显示出治疗癌症和神经系统疾病的前景. 本综述涵盖了CSF1R抑制剂的最新进展,重点关注其治疗潜力和输送系统.
科学领域:
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 殖民地刺激因子-1受体 (CSF1R) 是一种III型受体氨酸激酶,调节单核细胞群,包括微质细胞.
- 异常的CSF1R表达与瘤和神经退行性疾病有关.
- CSF1R信号通路对于细胞生存,增殖和分化至关重要.
研究的目的:
- 审查用于临床应用的CSF1R抑制剂的最新进展.
- 专注于瘤学和神经系统疾病的治疗进展.
- 讨论抑制剂结合方式,选择性,中枢神经系统透和毒性.
主要方法:
- 关于CSF1R抑制剂的最近研究的文献综述.
- 临床应用和疾病模型的分析.
- 检查有针对性的输送系统和抑制性质.
主要成果:
- 通过调节瘤微环境,CSF1R抑制剂为癌症治疗提供了一个有希望的策略.
- 向CSF1R对神经退行性和神经炎症性疾病有益.
- 抑制剂设计的进步旨在提高选择性和中枢神经系统透率,同时降低毒性.
结论:
- CSF1R 抑制剂代表了瘤学和神经学两方面的重要治疗途径.
- 进一步研究向输送和抑制剂优化对于临床成功至关重要.
- 调节CSF1R信号具有治疗一系列未满足需求的疾病的潜力.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


